Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance.
- NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_assertion description "[Since dysregulation of this pathway results in high, constitutive NF?B activation in various cancers and immune disorders, the development of specific drugs to target this pathway has become a focus for treating these diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance.
- NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_assertion evidence source_evidence_literature NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance.
- NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_assertion SIO_000772 22509977 NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance.
- NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_assertion wasDerivedFrom befree-2016 NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance.
- NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_assertion wasGeneratedBy ECO_0000203 NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance.
- befree-2016 importedOn "2016-02-19" NP975495.RA9id2qzjI_T9zCpDK1RYO4M6sd8C8zGzg-OJSOSM_aUY130_provenance.